Literature DB >> 8233545

Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat.

Jens D Kristensen1, Claes Post, Torsten Gordh, Björn A Svensson.   

Abstract

Drugs that antagonize the action of excitatory amino acids on the NMDA receptor in the spinal cord are of interest in pain treatment. Before such drugs can be applied clinically, their potential toxicity should be studied. This study was performed in rats in order to reveal possible neurotoxicologic side effects following chronic intrathecal (i.t.) application of two NMDA receptor antagonists: 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and kynurenic acid (KYN). Rats equipped with i.t. catheters were injected twice a day for 2 weeks with saline, 2 nmol (0.5 micrograms) CPP or 210 nmol (40 micrograms) KYN, where the doses of CPP and KYN were chosen on the basis of similar analgesic effects after one administration. Antinociception was tested daily using the tail-flick and hot-plate tests. The antinociceptive effect was similar in CPP- and KYN-treated rats on days 1 and 2. The effect of CPP decreased during the following days, whereas that of KYN persisted for the 12-day testing period. The spinal cord was then removed and prepared for light and electron microscopic examination, and a morphometric method using an unbiased stereological estimator of cell number and cell volume was applied as a sensitive variable of spinal cord neurotoxicity. Morphologic and ultrastructural analyses of the spinal cord segment adjacent to the tip of the catheter showed normal appearance with no differences between the groups. Furthermore, no differences in cell number or cell volume in the dorsal horn were found between the groups. In conclusion, chronic i.t. administration of pharmacologically active doses of CPP and KYN in rats did not produce neurotoxic effects in the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233545     DOI: 10.1016/0304-3959(93)90030-S

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  11 in total

Review 1.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

2.  Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex.

Authors:  Annamária Fejes-Szabó; Zsuzsanna Bohár; Enikő Vámos; Gábor Nagy-Grócz; Lilla Tar; Gábor Veres; Dénes Zádori; Márton Szentirmai; János Tajti; István Szatmári; Ferenc Fülöp; József Toldi; Árpád Párdutz; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2014-01-03       Impact factor: 3.575

3.  Inhibition of glial activation in rostral ventromedial medulla attenuates mechanical allodynia in a rat model of cancer-induced bone pain.

Authors:  Xijiang Liu; Huilian Bu; Cheng Liu; Feng Gao; Hui Yang; Xuebi Tian; Aijun Xu; Zhijun Chen; Fei Cao; Yuke Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

4.  Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro.

Authors:  Jolanta Parada-Turska; Wojciech Rzeski; Wojciech Zgrajka; Maria Majdan; Martyna Kandefer-Szerszeń; Waldemar Turski
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

5.  Percutaneous transforaminal epidural injection method in an experimental rat: minimally invasive drug delivery method to spinal epidural space.

Authors:  Nack Hwan Kim; Sang Heon Lee; Seok Jun Lee
Journal:  Ann Rehabil Med       Date:  2012-10-31

6.  Attenuation of morphine-induced antinociception by L-glutamic acid at the spinal site in rats.

Authors:  R K Srivastava; K K Gombar; A H Kaur; P Khosla
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

Review 7.  Management of painful diabetic neuropathy.

Authors:  P G Jensen; J R Larson
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

8.  Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives.

Authors:  Annamária Fejes; Arpád Párdutz; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

9.  Spinal Serotonergic and Opioid Receptors Are Involved in Electroacupuncture-Induced Antinociception at Different Frequencies on ZuSanLi (ST 36) Acupoint.

Authors:  Chi-Chung Kuo; Huei-Yann Tsai; Jaung-Geng Lin; Hong-Lin Su; Yuh-Fung Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

10.  Altered serum levels of kynurenine metabolites in patients affected by cluster headache.

Authors:  Martina Curto; Luana Lionetto; Andrea Negro; Matilde Capi; Francesca Perugino; Francesco Fazio; Maria Adele Giamberardino; Maurizio Simmaco; Ferdinando Nicoletti; Paolo Martelletti
Journal:  J Headache Pain       Date:  2016-03-22       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.